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Abstract  
The reuse of existing datasets to identify mechanisms for improving healthcare quality has been 
widely encouraged. There has been limited application within dementia care. Dementia Care 
Mapping (DCM) is an observational tool in widespread use, predominantly to assess and 
improve quality of care in single organisations. DCM data has the potential to be used for 
secondary purposes to improve quality of care. However, its suitability for such use requires 
careful evaluation. This study conducted in-depth interviews with 29 DCM users to identify 
issues, concerns and challenges regarding the secondary use of DCM data. Data was analysed 
using modified Grounded Theory. Major themes identified included the need to collect 
complimentary contextual data in addition to DCM data, to reassure users regarding ethical 
issues associated with storage and reuse of care related data and the need to assess and specify 
data quality for any data that might be available for secondary analysis.    
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Introduction  
With the aging population bringing about an increasing prevalence of dementia and associated 
economic, social, health and personal care costs, dementia has been made an internationa l 
health priority (Knapp et al., 2007; World Health Organization and Alzheimer’s Disease 
International, 2012; Prince et al., 2015).While there is extensive research into cure and 
symptom amelioration, improving the quality of life and quality of care for people living with 
the condition is a major global concern (WHO, 2012).  Governments, health and social-care 
providers, dementia-care organisations and charities therefore, promote not just medically 
driven research and interventions for the treatment and cure of dementia, but also social and 
psychological support and research for improving the quality of life and the quality of care.  
In 2013, a global dementia summit brought many countries together to pledge to improve 
dementia care (Department of Health, 2013). One major commitment within the resulting 
action plan was to commence initiatives for integrating data to enhance the opportunities for 
dementia research (Department of Health, 2013). In response to this, a recent report published 
by the Organisation for Economic Co-operation and Development (OECD) (Deetjen et al. , 
2015) proposed a big-data solution for dementia research. It defines big-data as both medically 
driven and non-medically driven data for dementia research, with the term ‘non-medica l ly 
driven data’ referring to data about people’s lifestyles, diets and food choices. The OECD 
report asserts that secondary analysis or reanalysis of currently available data across these 
medical and non-medical dimensions collectively, could support improvements to the care of 
people with dementia (Deetjen et al., 2015). While the current focus of the big-data proposal 
is to enhance research to support better dementia diagnosis, treatments, and a cure, dementia 
care related data could also provide a resource for understanding, assessing, comparing and 
improving existing care provision for people with dementia. However, to make dementia care 
related data part of ‘big-data’, appropriate datasets must be identified and examined for their 
suitability for potential secondary uses.   
Dementia Care Mapping (DCM) (Bradford Dementia Group, 1997;2005), an 
internationally used dementia care quality improvement tool (Brooker & Surr, 2005;2010), 
offers a dataset with considerable potential to improve quality of care beyond the settings in 
which it is collected and to enhance dementia care research.  
Dementia Care Mapping (DCM) 
DCM is an observational tool set within a practice development process for assessing and 
improving dementia care quality within formal dementia care settings (hospitals, care homes, 
day centers) (Bradford Dementia Group, 2005). It involves continual observation of between 
1 and 8 people with dementia over a period of time, usually between two and six consecutive 
hours, by a trained individual called a “mapper” (Bradford Dementia Group, 2005). During a 
single period of observation (called mapping), large amounts of data are collected. This can 
offer a rich picture of the person’s care experience, including the overall quality of care and 
factors that contribute to it. A full description of DCM can be found in Brooker and Surr (2006). 
However, in summary, the mapper records pre-defined codes representing each person’s 
behaviours (Behaviour Category Codes; BCC), mood and engagement (Mood and Engagement  
Codes; ME) and the quality of staff interactions with the person with dementia (Personal 
Enhancers; PE’s and Personal Detractions; PDs). Alongside this structured coding, qualitat ive 
data, in the form of notes about observations are also collected, providing additiona l 
information about the structured codes and the physical and social care environment. Once the 
observations are complete, a mapper processes the raw data and produces individual and group 
level summaries, such as percentages of time spent in each BCC and ME, the total number of 
PDs and PEs, and the average ME value over the observation period. This provides an indicator 
of the relative level of well or ill-being experienced during the mapping period (known as the 
well or ill-being - the WIB score) (Brooker & Surr, 2010). More detailed care quality indices 
can be completed by combining information about behaviour, mood and engagement to 
produce, for example, indicators of agitation, withdrawal and engagement in activit ies 
(Brooker & Surr, 2005).  
DCM has been used internationally as both a research tool and, more frequently, in 
practice development (Brooker, 2005; Younger & Martin, 2000; Cooke & Chaudhury, 2012). 
For practice development, DCM is conducted in a cycle of five phases including; briefing 
staff within the setting to be mapped about what DCM will involve, conducting the mapping 
observations, analysing the data and producing a report on the findings, feeding back the 
findings to staff and making action plans for improving care. The data and subsequent action 
plans can support care improvements to be made at individual patient, care setting (e.g. a 
hospital ward, day care center, and care home) and organisational (a body with one or more 
individual care settings) levels (British Standards Institution (BSI), 2010). For example, at a 
care setting level, DCM data has been used by managers for overall care quality monitoring 
(Packer et al., 1997) and identification of staff training and development needs (Lintern et al., 
2002). Further, DCM data taken from many care settings within one organisation can be used 
to audit levels of care and may be combined to identify general areas of good practice across 
an organisation (Baker, 2014). When used for practice development purposes, DCM is 
usually the sole data collected and is characteristically in a paper-based format, supported by 
analysis using basic spreadsheets and reported using word processing software.  
Within a research context, DCM has been used as an outcome measure for assessing 
behavioural patterns, levels of wellbeing, the quality of interactions with staff and quality of 
life of people with dementia (Brooker, 2005). It has been used to assess the efficacy of staff 
training, care quality and culture change projects (Lintern et al., 2002) as well as the efficacy 
of a range of interventions, including aromatherapy (Baker 2014), intergenerational activity 
programs (Jarrott & Bruno, 2003), horticultural therapy (Gigliotti & Jarrott, 2004) and 
reminiscence programs (Brooker & Duce, 2000). Where DCM is used as a research outcome 
measure, the cyclic practice development process is not usually followed and just the mapping 
and data analysis stages are completed. Standard statistical analysis software is commonly used 
for analysis, permitting superior manipulation of the data with more complexity than can be 
achieved from spreadsheets.  
In both practice development and research contexts use of DCM data primarily remains 
at a local level. That is, the individual (mapper or organisation or research study) collecting the 
data uses it within that setting or research project for the purpose it was originally collected 
(primary use). Despite the widespread primary uses of DCM and its importance for improving 
the quality of dementia care there has, to date, been a limited effort to explore potential for 
bringing together these multiple datasets and for reanalysis of that data (secondary use). In 
order to assess the potential of DCM data for secondary analysis, a clear understanding of the 
technical issues associated with combining these datasets in a repository known as a data 
warehouse and the social issues associated with mapper and end users issues, concerns and 
requirements for such a data warehouse is needed.  Data warehousing involves collecting and 
combining data from multiple sources into a data repository which stores data in a specific 
format (Inmon, 2012). While a previous study (Khalid et al., 2010) proposed a data warehouse 
as a technical solution for managing DCM data for potential secondary uses, without careful 
consideration of both technical and social issues, any future developments may encounter user 
acceptability problems which would impact on success of any technical solution for DCM.  
Therefore, this study aimed to investigate mappers’ perspectives on the potential issues 
with and concerns about secondary uses of DCM data in the context of future development of 
a data warehouse.   
Methods 
Design 
No research has previously been conducted regarding end users’ perspective on the potential 
secondary use of DCM data. Thus a qualitative methodology incorporating modified grounded 
theory (Strauss & Corbin, 1998), designed to understand study participants’ views at a 
conceptual level, was employed.   
Participants  
A purposive sample of 29 DCM mappers representing three main categories, researchers, 
trainers and practitioners was identified. These categories reflected the different roles people 
trained to use DCM might adopt. Researchers are those who use DCM for research purposes, 
trainers are experienced DCM practitioners who are trained and licensed to deliver DCM 
training to others and practitioners are those who use DCM for practice development purposes 
in care provider organisations. There was some overlap between the categories, since DCM 
trainers might also be using the tool for practice development and/or for research. There were 
two main reasons for approaching trained mappers as participants in this study. Firstly, they 
have a good understanding of DCM data due to their training in and experience of using DCM. 
Therefore, they are well placed to understand issues and challenges associated with secondary 
analysis of DCM data. Secondly, mappers’ views have always been considered important for 
any new development in DCM (Innes & Surr, 2003; Brooker & Roger, 2001; Brooker & Surr, 
2006) and are integral to acceptance of any development.  
 
Procedure 
Recruitment.  Potential participants from a range of UK-based organisations involved in 
dementia-care provision, monitoring, regulation and research, were contacted to take part in 
the study. They were identified through existing networks of the authors and via reviewing 
authorship of relevant published research. Potential participants were sent personalised emails 
inviting them to take part in the study and asked to reply if they were interested. One further 
reminder was sent to those who did not respond within two weeks. Those who replied were 
contacted again to arrange a time for interview at a location (face to face, or via Skype or 
phone), date and time convenient to them. 
 
Ethical Issues and consent. Ethics approval was sought via the University Ethics Review 
Procedure. Written informed consent was obtained from all participants ahead of interviews 
commencing.  
 
Interviews. To encourage the exploratory process, a semi-structured interview guide with broad 
topics was developed, which helped the study participants to talk about their perceptions, 
views, issues and concerns regarding the potential secondary uses of DCM data. Nineteen 
interviews were conducted face-to face and six were via Skype, all were audio recorded and 
transcribed. Interviews ranged in length from 45 to 60 minutes. Each participant was 
interviewed only once.  
A total of 29 interviews were conducted over three phases. See Table 1 (in Appendix, 
1) for participant details. During the first phase, 10 interviews were conducted with mappers 
spanning a variety of roles (practitioners, trainers and researchers) to explore their current use 
and their views about potential uses of DCM data. The second phase of data collection 
consisted of semi-structured interviews with 14 more participants (e.g. DCM trainers, 
researchers and practitioners) in order to collect more focused and detailed data. During the 
third phase, interviews were conducted with five researchers to further explain and clarify 
emerging views and issues.  
Data analysis 
Transcribed data from the interviews was managed using QSR Nvivo 9 (Bringer et al., 2006) 
and analysed using Strauss and Corbin’s (1998) open and axial coding techniques. Open coding 
is the initial step of data analysis using grounded theory, which Strauss and Corbin (1998) refer 
to as examining data at a micro level (i.e., looking at small details). The open coding identified 
a number of descriptive codes. These codes were merged into categories, based on conceptual 
similarities, where various aspects of the data were compared to formulate the differences and 
similarities within them. The emerged categories were linked based on the conceptual 
relationships between the data and high-level categories were formulated (axial coding) 
(Strauss & Corbin, 1998). Both open and axial coding continued until data was saturated and 
no new concepts and their relationships were emerging from the subsequent interview data. All 
coding was undertaken by (SK) and reviewed by (CS and NS) to check for agreement/accuracy 
of themes. 
Findings 
Three categories emerged: Potential secondary uses of DCM data; additional data 
requirements; and quality and security of DCM data for secondary uses.  
Potential secondary uses of DCM data  
The interview data highlighted that potential secondary uses of DCM data varied according to 
the previous experience people had. DCM Practitioners who were using DCM for practice 
development purposes, largely within their own organisations, envisaged that secondary 
analysis of DCM data could provide a mechanism for sharing good practice through processes 
such as benchmarking. DCM trainers, on the other hand, were interested in having access to 
historic and integrated DCM data to see trends and patterns, to identify and share good care 
practices and to use a variety of examples from the data within their DCM teaching. DCM 
researchers saw benefits in using DCM data to contribute to future research for example as a 
dataset they could draw on to conduct secondary research.  
 
Benchmarking. Benchmarking, defined as ‘the continuous and collaborative process of 
measuring and comparing the outcomes of key work processes with those of the best 
performers in evaluating organisational performance’ (Lovaglio, 2012, p. 2),  is a method 
organisations may use in order to make continuous quality improvements (Ettorchi-Tardy et 
al., 2012). Study participants saw this as a concept to identify a mechanism by which secondary 
DCM data could potentially be used to improve care quality. They saw two mechanisms for 
achieving this. The first was through using DCM data for internal benchmarking; meaning 
comparing either best practice with current practice within their own organisation (Lovaglio , 
2012). This would allow an examination of how far the quality of care they deliver was 
consistent across all parts of the organisation.  
‘It would be lovely if they [mappers] mapped in surgery and we could 
compare, yes, because it is a totally different environment and way of 
working, but if we are working really good, then it would be nice to see if we 
could transfer it or use it across. And for different areas…..I mean. It would 
be interesting seeing what they do and what could we do.’ (Practitioner, 12) 
Another potential use of DCM data was for external benchmarking. Here study 
participants expressed a desire to measure their own organisation’s performance against that of 
other similar organisations.  
‘….although our service is quite unique, but knowing about other services 
within the country and further afield, I think, would be really interesting.’ 
(Practitioner, 2) 
One participant saw this as a way of validating their own organisation’s standing, it 
would allow them to show that;  
‘We have reached that level of care, we are providing person-centred care 
and we can prove this through DCM’ (Practitioner Trainer, 10)   
This indicated that some mappers hoped that benchmarking might be able to offer a 
quantitative measure for what ‘good quality care’ or ‘person-centred care’ looks like and 
against which organisations could appraise their own performance.  
DCM teaching, training and support. The DCM trainers saw value in using DCM data for 
secondary purposes to improve training provision and to track trained mappers' professiona l 
development over time.  
‘I think it would be interesting to know the extent to which people [mappers] 
go on to actually use the tool after the training or particular reasons why 
they do and do they need support in using them? If they are not using it, then 
why they haven't managed to use it. I think that would be interesting to know.’ 
(Practitioner Trainer, 24) 
In addition to having access to data on the use of DCM by individual mappers, most 
DCM trainer interviewees also agreed that secondary data could enable them to learn from 
others' use of DCM and to identify examples of good care practices that could be used during 
delivery of DCM training courses. 
‘I think one of the things that across care settings says that we are not 
sharing good practice. There is a lot we can do in sharing to trigger ideas 
and factors.’ (Trainer, 18) 
‘One of the things is that, during the course, you can enrich the evidence 
with examples, which is possible by having access to the various types of 
data from this data warehouse.’ (Trainer, 26) 
Therefore, for trainers, a DCM data warehouse could enable information on DCM use 
to be made available, which could strengthen the ways in which they could better enable the 
use of DCM in practice through the training course and ongoing mapper support. 
Secondary research.  DCM researchers welcomed the potential use of DCM data for secondary 
research purposes. They hoped access to a data warehouse would permit exploration of data 
collected from a variety of care settings, across a range of geographical locations, over time, 
and for a multiplicity of purposes for the purpose of secondary analysis.  
‘I would be very fascinated in being able to extract back the information 
[DCM data] to see what behaviours people [residents] are experiencing in 
particular… if there is another organisation that is looking at mapping in a 
continuing care setting and being able to extract that for comparing and 
contrasting. So that is linking different organisations and settings together.’ 
(Researcher Practitioner Trainer, 17) 
Researchers also saw a DCM data warehouse as offering potential cost and time savings 
for researchers. 
‘I would love to use that data [secondary DCM data]. Because, now, so much 
time is taken doing mapping ourselves, which is enormous in time 
investment. It would be a great opportunity if you had a sort of a database 
where everyone put their data in and you can also use it for research 
purposes.’ (Researcher, 13) 
‘It would be extremely helpful, because now I have only my little sample to 
study my research question. But it would be really interesting, as it has not 
been studied before and it's a limitation of my study that there is such a small 
sample. So I would be really interested in using other mappers' data as well 
to have a bigger sample to study my research question.’ (Researcher, 4) 
While researchers saw wide benefits to the potential development of a DCM data 
warehouse, they were also clear in identifying a range of conditions that would need to be met 
in order for the data in the warehouse to be useable for secondary purposes. These included the 
need for additional data and for reassurance about data quality. 
Additional data requirements  
Interviewees identified that in order to be useful DCM data would need to be accompanied by 
a range of additional data within a warehouse, before they could use the data for research.   
‘I think it depends what other information is available on the study 
databases. If it was just DCM data with nothing else, then I think from… As 
a part of the dementia organisation, it would be valuable for us but as a 
researcher it would not be seen as particularly useful. But if you have 
neuropsychiatric inventory data, information on cognitive data, functional 
data, alongside, I think that would allow you to ask some interesting 
questions.’ (Researcher, 20) 
Additional data identified as required to provide crucial context to the DCM data could 
concern the individuals with dementia who had been mapped, the care setting where the 
observations were undertaken and details about staff members on duty during the mapping. 
The researchers were clear that without this data, it was unlikely that they would find DCM 
data useful for secondary research.  
‘I think you should think about this really hard upfront. Otherwise, the data 
[DCM data] cannot be used, if you don’t have all the required information. 
Like use of medication and all that information should have been in the 
database.’ (Researcher, 13) 
 
 Quality and security of DCM data for secondary uses 
Mappers across all three interviewee types raised concerns regarding the quality and security 
of DCM data in the context of its secondary use. This included the reliability and validity of 
the DCM data included in the warehouse, Reliability of DCM data is assessed through the inter-
rater reliability (IRR) process, which is where two or more mappers conduct mapping on the 
same people with dementia at the same time and compare the similarities and differences within 
their coded data (Bradford Dementia Group, 2005). They can work out a percentage of 
concordance which needs to be over 70% before data can be used for practice development 
purposes and 80% for research. For study participants, this inter-rater reliability of data was 
considered a significant factor in determining the quality of DCM data for secondary uses.  
‘You make reference to other people’s [DCM] data but you cannot be sure 
of the reliability of it. You would never be able to be certain of the reliability 
of other people’s data.’ (Researcher Practitioner Trainer, 16)  
As any secondary user of the data would not be the person or organisation involved in 
collecting the data they need to be reassured, via the data warehouse, that the data is of 
acceptable quality. Interviewees identified that this might be achieved by including information 
in the warehouse on mappers’ training level, experience and IRR score(s) alongside their DCM 
data.  
‘I want to see how the mappers have scored, if they are two mappers, have 
they correlated with each other to see if it [score] matches.’ (Researcher, 
13) 
Researcher 4: ‘She [friend] is a DCM trainer but with gold standard. But I 
am worried that, if I am going to use data from the regular mappers, how the 
quality of data I am going to look at…’ 
SK: What do you mean by a trainer with “gold standard”? 
Researcher 4: ‘I mean she has a lot of experience of mapping and she has 
trained many mappers so far and she is lead of DCM here in this country.’ 
It was only through providing this level of detail that the data in the warehouse would 
be seen as trustworthy by the potential end users. DCM researchers also raised concerns 
regarding ethical considerations that must to be adhered to when using healthcare data for 
research purposes. They stipulated a requirement to be able to find, alongside the DCM data, 
information including any approvals, consent processes and allied documentation.  
‘It’s very important that data is collected considering all ethical aspects. As 
a researcher, I would like to see what ethical considerations were taken when 
mapping was done.’ (Researcher, 25) 
While consent for observation is always gained when using DCM the information 
given, reasons for data use and informed consent procedures are not as rigorous in practice 
development as they are for research, as was highlighted by one respondent. 
‘So, for example, you imagine if it was your service and you know you were 
a key worker for five or six people and you measure their care using DCM, 
then I suppose, then you might not get ethical approval and you might not 
even get consent. You just do it as part of the care planning and I think there 
are issues around then what you can do with your data. The data stays as 
part of your care plan within your service and, if it is not shown to anybody 
else, then it’s fine. But when you start sharing all that anonymously, I think 
there will be ethical considerations around that, which need careful 
thought.’ (Researcher, 25) 
The interviewees also highlighted that, in addition to usual ethical processes there may 
be additional information for participants and formalised within consent forms to allow the 
retention and sharing of anonymised data for secondary use.    
‘The only thing, which is important, is that, if you collect data, you are doing 
it for one purpose and, if you use that data for other purposes, then you have 
to inform the care organisations where you mapped that you are going to 
share the data with other researchers. Because that is not the thing that you 
tell them at the start. So I think it is very important.’ (Researcher, 4) 
Discussion 
DCM data for benchmarking 
A successful benchmarking process requires data which is suitable, available, complete and 
accurate and that is comparable across settings (Campbell et al., 2003; Nolte, 2010). While our 
data reveals that those practitioners who use DCM data for internal benchmarking see 
additional value for external benchmarking, the feasibility of using DCM data in this way needs 
further exploration.  
DCM data is suitable in terms of providing a WIB score as an indicator to assess 
changes in care over time (Brooker et al., 1998). While there are suggestions in the literature 
that the mean WIB score across similar types of care settings can be used to indicate differences 
in care across setting types, there is no further evidence of the applicability of this data for 
identifying best practice or benchmarking. DCM data has also been used for comparison 
purposes while assessing changes in care across a number of settings (Brooker et al., 1998; 
Kuhn et al., 2002).  
Based on our findings and the literature review, the use of DCM data seems promising 
both in terms of users’ acceptability and the suitability of DCM data for benchmarking. 
DCM data for secondary research 
Reanalysis of DCM data for secondary purposes is infrequently reported in the literature. 
Examples of where it is used within the context of secondary research come from Fossey, Lee 
and Ballard (2002) who conducted secondary analysis of DCM data from three earlier studies 
in order to examine the psychometric properties of DCM as a research outcome measure and 
Innes and Surr (2001) who undertook a cohort analysis of data from two studies to describe 
standards of dementia care in UK care homes. Our findings show that study participants see 
value in reusing DCM data for secondary research. However, our study also underlines the 
need for additional information alongside the DCM data to make it a richer source for 
secondary research purposes. In reporting this we are consistent with other research that has 
discussed the need to report: participant characteristics such as age, gender, ethnicity, length of 
stay in health and social care facilities (Kuhn et al., 2005; Barnes et al., 2013); depression levels 
(Kuhn et al., 2004) and cognitive state (Kuhn et al., 2002); care setting characteristics such as 
type, location and size (Willemse et al., 2011) and staff-related information such as staff ratios 
and training (Gigliotti et al., 2004). This additional data is not routinely collected in a standard 
mapping process although it may be available from other sources such as electronic patient 
records.   
Within a secondary analysis, the DCM data and additional information about care 
settings, patients and staff could be explored to investigate potential associations that may only 
be identified through combining data from a large number of maps across a wide range of 
settings. The integration of such information could facilitate designing specific tailored 
interventions for similar patient groups to improve their care. Further, DCM data, alongside 
some additional information, could provide an opportunity to perform in-depth analysis about 
what, where, why and how well-being of people with dementia is influenced in formal care 
settings. 
Quality and security of DCM data for secondary uses 
Mappers expressed concerns regarding the quality and security of DCM data for secondary 
uses, particularly for secondary research. DCM data quality is an under-researched area. While 
for the primary use of data the literature highlights that data quality is associated with the 
mapper’s IRR score (Brooker et al., 1998; Thornton et al., 2004), there is a lack of any criteria 
for the quality of DCM data for secondary uses. According to the study participants, the 
mapper’s reliability, their experience and training levels, are significant for the secondary use 
of DCM data, particularly for research purposes. Further research is required to identify how 
mappers’ reliability for producing good quality DCM data can be regulated and monitored.  
Further, our study corroborates what other studies have reported in terms of ethical 
requirements for healthcare data. While primary use of healthcare data is concerned with 
patients’ own care and treatment, where practitioners or care providers are obliged to protect 
patients’ privacy, secondary use of the same data, particularly for research purposes, can raise 
additional data-protection and privacy concerns (Wiesenauer et al., 2012; Lamas et al., 2015). 
While it is necessary to gain patients’ consent for the secondary use of their data, the secondary 
use of DCM data might face additional consent-related issues. This requires establishing 
procedures that ensure an effective process of consent for the potential future secondary uses 
of DCM data. 
Limitations 
This study is limited to exploring only the views and perceptions of those individuals who were 
recruited based on their knowledge of DCM as mappers. It is important to seek views from 
those who might not be mappers but who would like to use DCM data for quality improvement 
and research purposes. These could be care-quality improvement organisations, universit ies 
and dementia charities. 
Conclusions 
The potential to utilise data sharing has attracted considerable interest in health and social care. 
This interest has been made possible by the increasing ubiquity of digitalisation and by 
enhanced technical possibilities in manipulating and sharing large and complex data sets. Even 
in the recent past, for example in the years when DCM was first used, these possibilities were 
either not there or the possibilities inherent in digital data were not so evident. But data sharing 
is not just a technical solution waiting to discover a research question. It is also attracting 
interest because of the cost benefits of reusing often expensively collected data. There are also 
ethical considerations that underline the need to maximise the usefulness of the data we get 
from people who are often sick and under considerable pressure, characteristically this is hard 
gained and generously given personal information that we need to make full use of. There are 
also academic reasons inherent in a recognition that we can do some things with large data sets, 
collected in multiple settings, that cannot be done with single site/single organisation studies. 
Many studies concerned with care of older people in general and of people with dementia in 
particular have been small scale studies. While these can be very valuable, utilising big data 
offers the possibility of a step change in the assessment of the efficacy of interventions and in 
the comparison of care modalities. DCM data has been collected, over twenty years, in a wide 
range of settings in different countries. It is rich and complex data that has used standard tools 
and been collected by people trained using the same protocols, and it has been stored in similar 
ways. It is data that relates to an identifiable population group in care settings that inc lude 
considerable similarities. As such this is data that appears very well suited for secondary uses. 
However to be able to ensure its potential secondary uses it must be stored in ways that permit 
secondary use and it must be made available in ways that facilitate reliable access, made as 
easy as possible. 
This paper has argued that DCM has potential to provide a basis for a dementia care 
quality dataset that may be used for secondary analysis purposes within practice and research 
contexts. It has also emphasised that the potential secondary uses of DCM data require the 
users to know that data they are using has been properly collected, meeting ethical standards 
and standards of accuracy and completeness. Extra categories need to be built into DCM data 
collection to routinely provide this and links made with other data sets that would allow for 
access to a more complete picture of the individual being mapped. To achieve this broadening 
of the scope and deepening the detail encompassed by DCM changes in training are required. 
The potential secondary use of DCM data will consequently enhance the national and 
international data-sharing culture in the DCM community and opportunities to make DCM data 
part of big-data for dementia research. 
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Appendix 1: Table 1: Participant details 
Participant code DCM Status Affiliations 
 Trainer 1 DCM Trainer University (UK) 
Practitioner 2  Basic DCM 
mapper 
Healthcare setting (UK) 
Practitioner 3 Basic DCM 
mapper 
Healthcare setting (UK) 
Researcher 4 Basic DCM 
mapper 
Research organisation (non-UK) 
DCM Practitioner 5 Advanced DCM 
mapper 
Healthcare setting (UK) 
Practitioner 6 Basic DCM 
mapper 
Healthcare setting (UK 
Practitioner 7 Basic DCM 
mapper 
Healthcare setting (UK) 
Researcher Practitioner 8 Advanced mapper University (UK) 
Researcher Practitioner 9 Basic DCM 
mapper 
University (UK) 
Practitioner Trainer 10 DCM trainer Research organisation and local dementia charity 
(non-UK) 
Researcher Trainer 11 DCM trainer Research organisation (non-UK) 
Practitioner 12 Basic DCM 
mapper 
Hospital setting (UK) 
Researcher 13 DCM mapper University (non-UK) 
Practitioner Trainer 14 DCM mapper Social care organisation (UK) 
researcher 15 Basic mapper University (UK) 
Researcher Practitioner Trainer 16 DCM trainer NHS trust (UK) 
Researcher Practitioner Trainer 17 DCM trainer NHS trust (UK) 
Trainer 18 DCM trainer University (UK) 
Trainer 19 DCM trainer University (UK) 
Researcher  20 Basic mapper Dementia charity (UK) 
Practitioner Trainer 21 DCM trainer UK 
Practitioner Trainer 22 DCM trainer UK 
Practitioner 
23 
Basic DCM 
mapper 
UK based dementia charity 
Trainer Practitioner 24 DCM trainer University (UK) 
Researcher 25 Basic DCM 
mapper 
University (non-UK) 
Practitioner Trainer 26 DCM trainer UK 
Researcher 27 Basic DCM 
mapper 
UK 
Researcher 28 Basic DCM 
mapper 
Dementia research organisation (Non-UK) 
Trainer 29 DCM trainer Dementia care organisation (Non-UK) 
 
 
 
 
